clinical trial · NCT00092963
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
Organon and Co·phase3·completed·n = 529
MigraineMK0462, rizatriptan benzoate / Duration of Treatment: 1dayComparator: placebo / Duration of Treatment: 1 day
brief summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.
started
Aug 17, 2004
primary completion
Jan 14, 2005
completion
Jan 14, 2005
last updated
Aug 14, 2024
official title
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol